Drug Manufacturers - Specialty & Generic | Healthcare
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Others segments. The company's Global Generics segment manufactures and markets prescription and over-the-counter finished pharmaceutical products that are marketed under a brand name or as a generic finished dosages with therapeutic equivalence to branded formulations, as well as engages in the biologics business. The PSAI segment manufactures and markets active pharmaceutical ingredients and intermediates, which are principal ingredients for finished pharmaceutical products. This segment also provides contract research services; and manufactures and sells active pharmaceutical ingredients and steroids in accordance with the specific customer requirements. The Others segment engages in developing therapies in the fields of oncology and inflammation; research and development of differentiated formulations; and provides digital healthcare and information technology enabled business support services. The company offers its products for various therapeutic categories primarily include gastro-intestinal, cardiovascular, anti-diabetic, dermatology, oncology, respiratory, stomatology, urology, and nephrology. Dr. Reddy's Laboratories Limited was incorporated in 1984 and is headquartered in Hyderabad, India.
Market Cap
1121368539136
Current Price
1347.7
52 Week Range
1020.0 - 1421.49
Previous Close
1348.8
Open
1350.0
Sector
Healthcare
Address
8-2-337, Road No. 3, Banjara Hills, Hyderabad, 500034, India
Phone
+91-40490-02900
Fax
+91-40490-02999
Website
https://www.drreddys.com
Day Low
1340.2
Day High
1351.0
Dividend Yield
0.61
PE Ratio
19.438913
Earnings Per Share
69.33
Beta
0.386
EBITDA
88840003584
Book Value
400.705
EPS
67.94299
Name | Title | Age | Year Born |
---|---|---|---|
Mr. Gunupati Venkateswara Prasad B.E. | Co-Chairman, MD & Member of Management Council | 64 | 1960 |
Mr. Kallam Satish Reddy B.Tech., M.S. | Chairman of the Board & Member of the Management Council | 57 | 1967 |
Mr. Erez Israeli M.B.A. | CEO & Member of the Management Council | 56 | 1968 |
Mr. Krishna K. Venkatesh B.Pharma M.S. | Global Head of Quality and Pharmacovigilance & Member of the Management Council | 51 | 1973 |
Ms. Archana Bhaskar B.Sc., M.B.A. | EVP, Head of Corporate Communications, Chief Human Resources Officer & Member of Management Council | 57 | 1967 |
Mr. Sanjay Sharma B.Tech. | Executive VP, Global Head of Global Manufacturing & Member of Management Council | 56 | 1968 |
Mr. Sushrut Kulkarni | Global Head of Integrated Product Development Organisation & Member of the Management Council | 54 | 1970 |
Richa Periwal | Head of Investor Relations and Analytics | - | - |
Mr. Kumar Randhir Singh | Company Secretary, Compliance Officer & Head of CSR | 74 | 1950 |
Ms. Sumera Hasham | Senior Director and Head of portfolio Strategy-Global Mktg. & External R&D & Chief Diversity officer | - | - |
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Find high-momentum stocks with strong forward PE ratios and moderate volatility for aggressive investors.
Explore stocks with high dividend yields and low debt-to-equity ratios for stable income.
Discover large-cap stocks with stable beta for lower volatility and reliable returns.
Find undervalued stocks with reasonable forward PE and market cap for value investors.
Discover stocks with strong 5-year revenue growth trading near their 52-week lows, ideal for long-term investment.
Explore high-beta stocks with significant price movement potential for risk-tolerant investors.
Discover mid to large-cap stocks with strong growth potential and attractive valuations.
Find affordable stocks with consistent dividend payouts for income-focused investors.